List of companies in Syncona Investment Management's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited. | ||||||
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics. | ||||||
Achilles Therapeutics is a personalized Cancer T cell Therapies targeting neoantigens founded in 2016. | ||||||
Freeline Therapeutics Limited is a Stevenage, England-based biotechnology company developing liver directed gene therapies for a range of diseases. | ||||||
Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020. | ||||||
Nightstar Therapeutics Limited was a London-based gene therapy company. | ||||||
Neogene Therapeutics, Inc. is a t Cell Therapies for Cancer founded in 2018. | ||||||
Blue Earth Diagnostics Limited is an Oxford-based developer and supplier of molecular imaging agents. | ||||||
Orbit Biomedical Limited is a Stevenage-based company founded in 2016 by Michael Keane. | ||||||
Macrophage cell therapy developer for the treatment of inflammatory and fibrotic diseases. | ||||||
Swanbio Therapeutics Limited is a London-based company founded in 2017 by Florian Eichler, Karen Kozarsky and Rachel Salzman. | ||||||
NightstaRx is a London-based company. |
